Oncology Nurse AdvisorLow-Dose Steroids Cut GVHD After Stem Cell TransplantMedPage TodayRisk stratification-directed, low-dose corticosteroid prophylaxis significantly decreased the incidence of acute graft-versus-host disease (GVHD) grades II to IV, i… Continue reading
Virtual-Strategy MagazineStem Cell Research Products Report 2016 – Analysis, Technologies & Forecasts – Key Vendors: BD Biosciences …Business Wire (press release)This report explores unique market opportunities by stem cell type, including mesenc… Continue reading
Moving Forward With Stem Cell Therapy – Online Event (September 6th-8th, 2016) – Research and MarketsBusiness Wire (press release)From basic research to clinical practice, this multi-disciplinary event provides an opportunity to share and compare resea… Continue reading
Moving Forward With Stem Cell Therapy – Online Event (September 6th-8th, 2016) – Research and MarketsBusiness Wire (press release)From basic research to clinical practice, this multi-disciplinary event provides an opportunity to share and compare resea… Continue reading
Moving Forward With Stem Cell Therapy – Online Event (September 6th-8th, 2016) – Research and MarketsBusiness Wire (press release)From basic research to clinical practice, this multi-disciplinary event provides an opportunity to share and compare resea… Continue reading
|
Asterias Biotherapeutics to Present at Stem Cell Summit 2016
PR Newswire (press release) The company’s proprietary cell therapy programs are based on its immunotherapy and pluripotent stem cell platform technologies. Asterias is presently focused on advancing three clinical-stage programs which have the potential to address areas of very … |